Texas Tech University Health Sciences Center

Dr. Jon Weidanz, MPH, Ph.D., Joins BioNTX Board of Directors

Retrieved on: 
Monday, October 30, 2023

ARLINGTON, Texas, Oct. 30, 2023 /PRNewswire/ -- BioNTX , the bioscience and healthcare innovation trade organization in North Texas, is proud to announce the appointment of Jon Weidanz, MPH, Ph.D., as its newest member of the Board of Directors.

Key Points: 
  • ARLINGTON, Texas, Oct. 30, 2023 /PRNewswire/ -- BioNTX , the bioscience and healthcare innovation trade organization in North Texas, is proud to announce the appointment of Jon Weidanz, MPH, Ph.D., as its newest member of the Board of Directors.
  • His addition to the board underscores BioNTX's commitment to innovation and excellence in the biotechnology industry.
  • "I am excited and honored to join BioNTX and contribute to its mission of advancing healthcare through cutting-edge biotechnology," expressed Dr. Jon Weidanz.
  • BioNTX continues to demonstrate its commitment to attracting top-tier talent and expanding its capabilities to revolutionize healthcare and bioscience.

Opening of TMC3 Collaborative Building Marks Launch of Helix Park, a 37-acre Campus Fostering Innovation in Healthcare and Life Science

Retrieved on: 
Thursday, October 26, 2023

The 250,000-square foot TMC3 Collaborative Building is located at the heart of Helix Park and incorporates research initiatives for the four founding institutions.

Key Points: 
  • The 250,000-square foot TMC3 Collaborative Building is located at the heart of Helix Park and incorporates research initiatives for the four founding institutions.
  • Designed to foster collaboration between academic institutions and industry partners, the building includes purpose-built wet laboratories and office/co-working space to facilitate the seamless exchange of life science ideas and advancements.
  • In addition, the building will host commercial life sciences companies including Portal Innovations, as well as the TMC Venture Fund.
  • The TMC3 Collaborative Building was designed by Boston-based Elkus Manfredi Architects, one of the nation’s premier life science architectural firms.

2023-24 Fellows of HACU’s Leadership Academy/La Academia de Liderazgo Announced

Retrieved on: 
Monday, September 11, 2023

SAN ANTONIO, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The Hispanic Association of Colleges and Universities is pleased to announce the 50 fellows who will be part of the fifth cohort of its Leadership Academy/La Academia de Liderazgo.

Key Points: 
  • SAN ANTONIO, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The Hispanic Association of Colleges and Universities is pleased to announce the 50 fellows who will be part of the fifth cohort of its Leadership Academy/La Academia de Liderazgo.
  • The program is designed to increase diverse representation in executive and senior-level positions in higher education.
  • The first seminar will be held in October 2023 in conjunction with HACU’s 37th Annual Conference in Chicago, Illinois.
  • Special thanks to Capital One and American Federation of Teachers (AFT) for their support in providing fellowships to selected recipients.

Texas Tech University Health Sciences Center Partners with Deep 6 AI to Launch an AI Program for Clinical Trials

Retrieved on: 
Tuesday, August 1, 2023

PASADENA, Calif., Aug. 1, 2023 /PRNewswire/ -- Texas Tech University Health Sciences Center (TTUHSC) and Deep 6 AI announced a collaboration, joining forces to integrate artificial intelligence (AI) within TTUHSC's electronic medical record (EMR) system to improve patient access to clinical trials.

Key Points: 
  • PASADENA, Calif., Aug. 1, 2023 /PRNewswire/ -- Texas Tech University Health Sciences Center (TTUHSC) and Deep 6 AI announced a collaboration, joining forces to integrate artificial intelligence (AI) within TTUHSC's electronic medical record (EMR) system to improve patient access to clinical trials.
  • TTUHSC will use Deep 6 AI to precision-match patients to their clinical trials in real time.
  • This process will allow researchers to find the right patients for their trials in minutes, which will greatly reduce the workload on their staff.
  • "By integrating with TTUHSC's EMR, Deep 6 AI's software platform can precision-match patients to trials in minutes.

UMC Health System Deploys ZeroEyes' AI Solution to Deter and Mitigate Gun-Related Violence While Maintaining Accessibility

Retrieved on: 
Tuesday, July 18, 2023

Healthcare workers, who served and sacrificed tremendously through the pandemic, now face an increased risk at work.

Key Points: 
  • Healthcare workers, who served and sacrificed tremendously through the pandemic, now face an increased risk at work.
  • Healthcare facilities must be accessible to visitors and new patients, but this open-door policy unavoidably increases the threat of violence.
  • "UMC is the first hospital in the region to employ AI-based gun detection security measures," said Mark Funderburk, Chief Executive Officer, UMC Health System.
  • We are extremely proud that UMC has stepped forward, choosing ZeroEyes as its gun detection and intelligent situational awareness partner."

Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society Symposium

Retrieved on: 
Wednesday, June 28, 2023

SOLANA BEACH, Calif., June 28, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced its continued sponsorship of The William A. Devane Early Career Investigator Award at the 33rd International Cannabinoid Research Society (ICRS) Symposium in Toronto, Ontario, Canada.

Key Points: 
  • SOLANA BEACH, Calif., June 28, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced its continued sponsorship of The William A. Devane Early Career Investigator Award at the 33rd International Cannabinoid Research Society (ICRS) Symposium in Toronto, Ontario, Canada.
  • Artelo congratulates the 2023 recipient of The William A. Devane Early Career Investigator Award Josée Guindon, Ph.D., Associate Professor, Department of Pharmacology and Neurosciences, at Texas Tech University Health Sciences Center.
  • “We are extremely pleased to be an integral part of the annual ICRS symposia as the sponsor of The William A. Devane Early Career Investigator Award for the past five years," said Gregory Gorgas, Chief Executive Officer of Artelo.
  • “We look forward to collaborating with additional top tier researchers recognized at the ICRS as we advance our novel product candidates,” continued Mr. Gorgas.

Wolters Kluwer Webinar Brings Together Nursing Leaders to Discuss New Technologies

Retrieved on: 
Friday, June 9, 2023

Across industries, the influx of new technology is continuing to roll out at a break-neck pace, with artificial intelligence (AI) at the forefront.

Key Points: 
  • Across industries, the influx of new technology is continuing to roll out at a break-neck pace, with artificial intelligence (AI) at the forefront.
  • To examine the opportunities and risks in using new technologies for research, evidence based practice (EBP) and quality improvement (QI) Wolters Kluwer Health , will host an online event titled, “ Achieving academic excellence in nursing with new technologies: An Ovid® Synthesis webinar ,” on Tuesday, June 13th from 2 to 3pm ET.
  • Wolters Kluwer Health provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare.
  • The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Retired Vice Admiral Raquel “Rocky” C. Bono, Former Director of the Defense Health Agency, Joins Red Cell Partners as a Senior Advisor and the Board of TARA Mind

Retrieved on: 
Thursday, June 1, 2023

Red Cell Partners (Red Cell), an incubation firm building technology-centered companies that are bringing revolutionary advancements to market in national security and healthcare, today announced that Vice Admiral (Retired) Raquel “Rocky” C. Bono, MD, MBA, FACS, has joined as a Senior Advisor.

Key Points: 
  • Red Cell Partners (Red Cell), an incubation firm building technology-centered companies that are bringing revolutionary advancements to market in national security and healthcare, today announced that Vice Admiral (Retired) Raquel “Rocky” C. Bono, MD, MBA, FACS, has joined as a Senior Advisor.
  • Bono, who made history as the Navy’s first female medical officer to achieve the rank of three-star admiral, will also bring her decades of expertise to the Board of Red Cell portfolio company, TARA Mind .
  • “What we do in health and medicine provides the foundation for functional and robust economic systems and is therefore critical to national security.
  • To be part of an organization like Red Cell whose mission is so in line with my own personal and professional beliefs represents a rare opportunity.

The International Myeloma Foundation (IMF) Launches Medical Student Scholars for Health Equity in Myeloma Mentoring Program

Retrieved on: 
Thursday, April 20, 2023

STUDIO CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) has partnered with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program to develop a mentoring program for African American medical school students.

Key Points: 
  • STUDIO CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) has partnered with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program to develop a mentoring program for African American medical school students.
  • On how the Medical Student Scholars for Health Equity in Myeloma Mentoring Program came about, Dr. Mikhael narrates: “The Medical Student Scholars for Health Equity in Myeloma is a brand-new program launched by the IMF in collaboration with the National Medical Association and the W. Montague Cobb Institute (their research arm).
  • That's why we are partnering with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program and the National Medical Association in creating the Medical Student Scholars for Health Equity in Myeloma Mentoring Program.
  • To learn more about the Medical Student Scholars for Health Equity in Myeloma Mentoring Program, visit the IMF M-Power website .

2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund Palo Santo

Retrieved on: 
Thursday, March 9, 2023

Palo Santo , a venture capital fund focused on emerging psychedelic healthcare market, announced it will participate in several SXSW Psychedelics Tracks including:

Key Points: 
  • Palo Santo , a venture capital fund focused on emerging psychedelic healthcare market, announced it will participate in several SXSW Psychedelics Tracks including:
    Featured Session: To Trip or Not to Trip : Saturday, March 11, 2023 11:30 a.m. to 12:30 p.m. CT at the Austin Convention Center in Room 16AB – Join some of the leading researchers who will share their perspectives on the future of psychedelic science.
  • Those with decades of experience have knowledge that is crucial to finding the right paths forward as psychedelics go mainstream.
  • The psychedelic science torch is getting passed to the next generation, with fresh perspectives on both ancient and future medicines.
  • Sinai) and Palo Santo Cofounder Tim Schlidt explore the future of psychedelic science.